Inflammatory Breast Cancer: Dynamic Contrast-enhanced MR in Patients Receiving Bevacizumab Initial Experience
Arpi Thukral, David M. Thomasson, Catherine K. Chow, Reyes Eulate, Suparna B. Wedam, Sandeep N. Gupta, Betty J. Wise, Seth M. Steinberg, David J. Liewehr, Peter L. Choyke, and Sandra M. Swain
Radiology 2007;244 727-735
http://radiology.rsnajnls.org/cgi/content/abstract/244/3/727?etoc
We found that the MR-derived integrated area under the gadolinium concentration curve and general kinetic model parameters forward transfer rate constant and backflow compartmental rate constant extravascular and extracellular to plasma were the most strongly associated with changes in inflammatory breast cancer response after treatment with bevacizumab alone and combination bevacizumab therapy and chemotherapy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment